𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatments for metastatic melanoma: Synthesis of evidence from randomized trials

✍ Scribed by Philip Lui; Richard Cashin; Márcio Machado; Michiel Hemels; Patricia K. Corey-Lisle; Thomas R. Einarson

Book ID
116395137
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
241 KB
Volume
33
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase III randomized trial of dacarbaz
A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma
✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast

Randomized trial of radiotherapy versus
Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain
✍ Harmon J Eyre; Joel D Ohlsen; Jess Frank; Albert F LoBuglio; Joseph D McCracken; 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 358 KB

One hundred sixteen eligible patients with metastatic cancer to the brain were randomized to receive either radiotherapy 3000 rad/!0 fractions (treatment l) or the same radiotherapy plus metronidazole 6 gm/m 2 (treatment 2). One hundred eleven patients were either fully or partially evaluable. The r